Related Experiment Video
Updated: Jun 16, 2026
09:31
Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
Published on: March 30, 2018
Stem cell therapy: pieces of the puzzle
John A Schoenhard1, Antonis K Hatzopoulos
1Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, MRB IV P425C, 2213 Garland Avenue, Nashville, TN 37232, USA.
Journal of Cardiovascular Translational Research
|February 2, 2010
Summary
Cellular therapy shows promise for treating heart failure by improving heart function after injury. Ongoing research focuses on enhancing cell survival and effectiveness for better cardiac repair.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Cell Biology
Background:
- Heart failure often results from irreversible cardiac tissue loss due to ischemic injury or cardiomyopathies.
- Cellular therapy presents a novel therapeutic approach for managing heart disease.
- Previous studies in animal models demonstrated improved ventricular function following cell transplantation.
Purpose of the Study:
- To review the progress and current state of cellular therapy for heart failure treatment.
- To highlight ongoing research efforts in optimizing cell-based cardiac repair strategies.
- To discuss challenges and future directions in the field of cardiac cell therapy.
Main Methods:
- Review of current scientific literature and clinical trial data on stem cell therapies for heart disease.
- Analysis of research focused on cell source comparison, delivery methods, and cell engraftment.
- Examination of strategies to enhance transplanted cell survival and promote cardiomyocyte differentiation.
Main Results:
- Early clinical trials show encouraging outcomes in patients undergoing cellular therapy for heart failure.
- Limited long-term data exists regarding the survival and integration of transplanted cells.
- Research is actively exploring methods to improve cell homing, survival, and functional differentiation within the myocardium.
Conclusions:
- Cellular therapy holds significant potential for treating heart failure, with early clinical results being promising.
- Further research is crucial to overcome challenges related to cell survival, delivery, and differentiation for widespread clinical application.
- Optimizing cell-based strategies is key to advancing regenerative medicine for cardiac repair.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...